Company Filing History:
Years Active: 2010
Title: Mi Sun Kim: Innovator in Plant Biotechnology
Introduction
Mi Sun Kim is a prominent inventor based in Daejeon, South Korea. She has made significant contributions to the field of plant biotechnology, particularly in the area of genetic engineering. Her work focuses on developing transformed plant cells that can express specific genes related to human health.
Latest Patents
Mi Sun Kim holds a patent for a transformed plant cell expressing tandem repeats of the beta-amyloid gene. This invention is particularly relevant as beta-amyloid is known to be a causal substance of senile dementia in humans. The patent describes a transformed plant cell that expresses multiple beta-amyloid proteins, which can be effectively utilized in the preparation of an oral vaccine composition aimed at preventing senile dementia.
Career Highlights
Mi Sun Kim is affiliated with the Korea Research Institute of Bioscience and Biotechnology. Her research has garnered attention for its potential applications in medicine and agriculture. She has dedicated her career to exploring innovative solutions to pressing health issues through plant biotechnology.
Collaborations
Some of her notable coworkers include Hyun Soon Kim and Jung Won Youm. Their collaborative efforts contribute to the advancement of research in the field of bioscience and biotechnology.
Conclusion
Mi Sun Kim's innovative work in plant biotechnology exemplifies the intersection of science and health. Her contributions, particularly in developing solutions for senile dementia, highlight the importance of research in improving human health through innovative technologies.